New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations
May 6, 2019
| By Diane Mapes / Fred Hutch News Service
Researchers at Fred Hutch are using a type of artificial intelligence called natural language processing, or NLP, to delve into the pathology reports of metastatic non-small cell lung cancer patients to find if they have two treatable mutations. Dr. Bernardo Goulart tells us why.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.